Redmile Group, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share (RAPT)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
RAPT
Shares outstanding
140,731,808 shares
Disclosed Ownership
13,932,449 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 20:02:25 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 9.9% 13,932,449 0 13,932,449 /s/ Jeremy C. Green Managing Member
Jeremy C. Green 9.9% 13,932,449 0 13,932,449 /s/ Jeremy C. Green Jeremy C. Green
Redmile Biopharma Investments III, L.P. 5.4% 7,559,323 0 7,559,323 /s/ Jeremy C. Green Managing Member of Redmile Biopharma Investments III (GP), LLC, general partner of Redmile Biopharma Investments III, L.P.